Skip to main content

Search from vocabulary

Content language

Concept information

Preferred term

Enprostil  

Type

  • Topical Descriptor

Entry terms

  • Enprostil, (1alpha,2alpha(1E,3S*),3beta)-(+-)-Isomer
  • Enprostil, (1alpha,2beta(1E,3R*),3alpha)-(+-)-Isomer
  • Enprostil, (1alpha(R*),2beta(1E,3R*),3alpha)-(+-)-Isomer
  • Enprostil, (1alpha(R*),2beta(1E,3S*),3alpha)-(+-)-Isomer
  • Enprostil, (1R-(1alpha,2beta(1E,3R*),3alpha))-Isomer
  • Enprostil, (1R-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer
  • Enprostil, (1R-(1(R*),2beta(1E,3R*),3alpha))-Isomer
  • Enprostil, (1S-(1alpha(R*),2beta(1E,3R*),3alpha))-Isomer
  • Enprostil, (1S-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer
  • Gardrin
  • RS 84135
  • RS-84135
  • RS84135

Scope note

  • A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.

History note

  • 92; was ENPROSTIL (NM) 1985-91

In other languages

URI

http://www.yso.fi/onto/mesh/D016620

Download this concept:

RDF/XML TURTLE JSON-LD Created 1/25/91, last modified 6/8/15